Skip to main content
SpringerLink
Log in

Multiple vertebral fractures as the first manifestation of systemic mastocytosis

  • Case Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Systemic mastocytosis is a clonal disease of the mast cell progenitors of the bone marrow. The clinical picture varies from asymptomatic (indolent) to highly aggressive (mast cell leukemia). Up to one-third of patients with SM have osteoporosis and fractures. The following is an analysis of the case of a young patient with multiple fractures as the first manifestation of SM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Horny HP, Sotlar K, Valent P (2007) Mastocytosis: state of the art. Pathobiology 74:121–132

    Article  CAS  PubMed  Google Scholar 

  2. Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NAT, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Investig 37:435–453

    Article  CAS  Google Scholar 

  3. Gülen T, Hägglun H, Dahlen B, Nilsson G (2015) Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease (review). J Intern Med 279(3):211–228

  4. Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bonadonna P, Schena D, Escribano L, Adami S, Gatti D (2014) Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin N Am 34(2):383–396

    Article  Google Scholar 

  5. Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int 4:368–381

    Article  CAS  PubMed  Google Scholar 

  6. Degboé Y, Eischen M, Nigon D, Apoil PA, Mailhol C, Tournier E, Laurent C, Hanssens K, Hermine O, Paul C, Laroche M, Bulai-Livideanu C (2017) Prevalence and risk factors for fragility fracture in systemic mastocytosis. Bone 105:219–225

    Article  PubMed  Google Scholar 

  7. Van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ (2012) High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy 67(3):431–438

    Article  CAS  PubMed  Google Scholar 

  8. Delling G, Ritzel H, Werner M (2001) Histological characteristic and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis of 158 cases. Pathologe 22:132–140

    Article  CAS  PubMed  Google Scholar 

  9. Van der Veer E, Arends S, Van der Hoek S et al (2014) Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis. J Allergy Clin Immunol 134(6):1413–1421

    Article  PubMed  Google Scholar 

  10. Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112:946–955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schwartz LB (1987) Mediators of human mast cells and human mast cell subsets. Ann Allergy 58:226–235

    CAS  PubMed  Google Scholar 

  12. Macpherson JL, Kemp A, Rogers M et al (1989) Occurrence of plateletactivating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Clin Exp Immunol 77:391–396

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Theoharides TC, Boucher W, Spear K (2002) Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 128:344–350

    Article  CAS  PubMed  Google Scholar 

  14. Brockow K, Akin C, Huber M, Metcalfe DD (2005) IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol 115:216–223

    Article  CAS  PubMed  Google Scholar 

  15. Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36:32–36

    Article  CAS  PubMed  Google Scholar 

  16. Seitz S, Barvencik F, Koehne T, Priemel M, Pogoda P, Semler J, Minne H, Pfeiffer M, Zustin J, Püschel K, Eulenburg C, Schinke T, Amling M (2013) Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int 24:2325–2334

    Article  CAS  PubMed  Google Scholar 

  17. Rossini M, Zanotti R, Viapiana O et al (2014) Zoledronic acid in osteoporosis secondary to mastocytosis. Am J Med 127(1127):e1121–e1124

    Google Scholar 

  18. Zhu JJ, Mahendran D, Lee MH, Seah J, Fourlanos S, Varadarajan S, Ghasem-Zadeh A, MacIsaac RJ, Seeman E (2018) Systemic mastocytosis identified in two women developing fragility fractures during lactation. Osteoporos Int 29(7):1671–1674

    Article  CAS  PubMed  Google Scholar 

  19. Rossini M, Zanotti R, Orsolini G, Tripi G, Viapiana O, Idolazzi L, Zamò A, Bonadonna P, Kunnathully V, Adami S, Gatti D (2016) Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. Osteoporos Int 27:2411–2421

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology, Hospitales San Roque Las Palmas De Gran Canaria, Las Palmas, Spain

    Á. Acosta-Mérida

  2. Rheumatology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, Spain

    S. Ojeda-Bruno

Authors
  1. Á. Acosta-Mérida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ojeda-Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Á. Acosta-Mérida.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acosta-Mérida, Á., Ojeda-Bruno, S. Multiple vertebral fractures as the first manifestation of systemic mastocytosis. Osteoporos Int 30, 1121–1124 (2019). https://doi.org/10.1007/s00198-019-04897-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-019-04897-9

Keywords

Search

Navigation